Shenzhen new industries biomedical engineering (300832.SZ): has obtained the registration certificate for the complement C3 assay kit (immunoturbidimetric method) medical instruments.

Shenzhen New Industries Biomedical Engineering (300832.SZ) announced on November 26th that the company recently received a 'medical instruments registration certificate' issued by the Guangdong Pharmaceutical Supervision Administration. The product is named Complement C3 Assay Kit (immunoturbidimetry), with registration number Yue Equipment Standard 20242401551, valid from November 21, 2024, to November 20, 2029. This assay kit is used for quantitative determination of complement C3 in human serum and plasma, clinically used for auxiliary diagnosis of complement deficiencies or related immunodeficiency diseases. This certification enriches the company's biochemical testing products.

Gelonghui FinanceNov 26 04:30 ET

shenzhen new industries biomedical engineering (300832.SZ): Received a medical instruments registration certificate.

Gelonghui reported on November 21 that shenzhen new industries biomedical engineering (300832.SZ) announced that recently, it received a medical instruments registration certificate issued by the Guangdong Provincial Drug Administration. This is for the cyclosporine assay kit (magnetic microparticle chemiluminescence method).

Gelonghui FinanceNov 21 04:26 ET

Is Shenzhen New Industries Biomedical Engineering Co., Ltd.'s (SZSE:300832) Stock's Recent Performance A Reflection Of Its Financial Health?

Simply Wall StNov 17 19:42 ET

Shenzhen New Industries Biomedical Engineering Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

Simply Wall StOct 30 19:42 ET

New Industries: 2024 Third Quarter Report

SZSIOct 28 12:00 ET · Announcements

Shenzhen New Industries Biomedical Engineering (300832.SZ) released its performance for the first three quarters, with a net income of 1.384 billion yuan, an increase of 16.59%.

shenzhen new industries biomedical engineering (300832.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters reaching 34...

Zhitong FinanceOct 28 10:19 ET